Neurogene (NASDAQ:NGNE) Receives Outperform Rating from William Blair

William Blair reiterated their outperform rating on shares of Neurogene ( NASDAQ:NGNE – Free Report ) in a report released on Tuesday, RTT News reports. William Blair also issued estimates for Neurogene’s Q4 2024 earnings at ($1.04) EPS, FY2024 earnings at ($4.33) EPS, Q1 2025 earnings at ($1.08) EPS, Q2 2025 earnings at ($1.05) EPS, Q3 2025 earnings at ($1.09) EPS, Q4 2025 earnings at ($1.11) EPS and FY2025 earnings at ($4.32) EPS. NGNE has been the subject of a number of other research reports. HC Wainwright reiterated a “buy” rating and set a $55.00 price objective on shares of Neurogene in a research note on Tuesday. BMO Capital Markets lowered their price objective on Neurogene from $65.00 to $60.00 and set an “outperform” rating for the company in a research note on Tuesday, November 12th. Robert W. Baird boosted their price target on Neurogene from $54.00 to $72.00 and gave the stock an “outperform” rating in a research note on Tuesday, November 12th. Leerink Partners boosted their price target on Neurogene from $45.00 to $72.00 and gave the stock an “outperform” rating in a research note on Tuesday, November 12th. Finally, Stifel Nicolaus boosted their price target on Neurogene from $44.00 to $60.00 and gave the stock a “buy” rating in a research note on Tuesday, November 12th. Eight analysts have rated the stock with a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Buy” and a consensus price target of $60.83. Read Our Latest Stock Analysis on Neurogene Neurogene Trading Up 30.2 % Institutional Trading of Neurogene Hedge funds have recently bought and sold shares of the company. Driehaus Capital Management LLC increased its position in Neurogene by 123.8% during the second quarter. Driehaus Capital Management LLC now owns 102,187 shares of the company’s stock valued at $3,719,000 after acquiring an additional 56,533 shares during the last quarter. Bank of New York Mellon Corp purchased a new stake in Neurogene during the second quarter valued at $1,107,000. Vanguard Group Inc. increased its position in Neurogene by 906.5% during the first quarter. Vanguard Group Inc. now owns 507,483 shares of the company’s stock valued at $25,831,000 after acquiring an additional 457,062 shares during the last quarter. Marshall Wace LLP increased its position in Neurogene by 37.2% during the second quarter. Marshall Wace LLP now owns 41,447 shares of the company’s stock valued at $1,508,000 after acquiring an additional 11,229 shares during the last quarter. Finally, Integral Health Asset Management LLC purchased a new stake in Neurogene during the second quarter valued at $2,547,000. Hedge funds and other institutional investors own 52.37% of the company’s stock. About Neurogene ( Get Free Report ) Neurogene Inc, a biotechnology company, develops genetic medicines for rare neurological diseases. The company's product candidates include NGN-401 which is packaged in an adeno-associated virus 9 that is in Phase 1/2 clinical trial for the treatment of Rett syndrome; and NGN-101, a conventional gene therapy candidate that is in Phase 1/2 clinical trial to treat CLN5 Batten disease. Read More Receive News & Ratings for Neurogene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neurogene and related companies with MarketBeat.com's FREE daily email newsletter .Police are investigating a shooting where bullets hit a number of parked cars and a house in Pitt Meadows in the early morning hours of Sunday, Nov. 24. The Ridge Meadows RCMP say just after 4:30 a.m. officers responded to reports of shots fired in the 18800 block of 122nd Avenue, which is a residential neighbourhood. Responding officers found nobody was injured in the incident, however damage was located on "several" parked vehicles and a nearby residence. “We are thankful that nobody was injured in this early morning shooting that occurred in a residential area of Pitt Meadows,” said A/Sgt. Sunny Grewal with the Ridge Meadows Investigative Support Team. According to a social media report, a camera in the neighbourhood recorded about 10-11 shots from a firearm. The Ridge Meadows Investigative Support Team took conduct of the file, and attended the scene along with the Integrated Forensic Identification Section. “As this incident is still under investigation, we are asking for anyone who has information on this incident to please contact the police,” said Grewal. Police are seeking witnesses or persons who may have dash camera footage and/or surveillance video from the area. Anyone with information regarding this investigation is asked to contact the Ridge Meadows RCMP at 604-463-6251 and quote file number 2024-23981. In 2021, a house on the same street suffered damage from bullet holes after an overnight shooting, but police reported at that time it was the wrong address that had been targeted.

Healthy Ravens Squad Set to Face Giants' Tommy DeVito - BaltimoreRavens.com

Girls soccer photos: Group 4 final - Westfield vs. Eastern, Saturday, Nov. 23The 5 step plan Princess Andre, 17, is using to be the next Molly-Mae, and it’s setting her up to be a millionaire by 20